These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 11277649

  • 1. Concomitant radiotherapy and paclitaxel for high-risk endometrial cancer: first feasibility study.
    Frigerio L, Mangili G, Aletti G, Carnelli M, Garavaglia E, Beatrice S, Ferrari A.
    Gynecol Oncol; 2001 Apr; 81(1):53-7. PubMed ID: 11277649
    [Abstract] [Full Text] [Related]

  • 2. Adjuvant paclitaxel and carboplatin chemotherapy with involved field radiation in advanced endometrial cancer: a sequential approach.
    Lupe K, Kwon J, D'Souza D, Gawlik C, Stitt L, Whiston F, Nascu P, Wong E, Carey MS.
    Int J Radiat Oncol Biol Phys; 2007 Jan 01; 67(1):110-6. PubMed ID: 17084542
    [Abstract] [Full Text] [Related]

  • 3. Preliminary analysis of RTOG 9708: Adjuvant postoperative radiotherapy combined with cisplatin/paclitaxel chemotherapy after surgery for patients with high-risk endometrial cancer.
    Greven K, Winter K, Underhill K, Fontenesci J, Cooper J, Burke T, Radiation Therapy Oncology Group.
    Int J Radiat Oncol Biol Phys; 2004 May 01; 59(1):168-73. PubMed ID: 15093913
    [Abstract] [Full Text] [Related]

  • 4. Adjuvant treatment with concomitant radiotherapy and chemotherapy in high-risk endometrial cancer: a clinical experience.
    De Marzi P, Frigerio L, Cipriani S, Parazzini F, Busci L, Carlini L, Viganò R, Mangili G.
    Gynecol Oncol; 2010 Mar 01; 116(3):408-12. PubMed ID: 20022359
    [Abstract] [Full Text] [Related]

  • 5. A pilot trial of TAC (paclitaxel, doxorubicin, and carboplatin) chemotherapy with filgastrim (r-metHuG-CSF) support followed by radiotherapy in patients with "high-risk" endometrial cancer.
    Duska LR, Berkowitz R, Matulonis U, Muto M, Goodman A, McIntyre JF, Klein A, Atkinson T, Seiden MV, Campos S.
    Gynecol Oncol; 2005 Jan 01; 96(1):198-203. PubMed ID: 15589601
    [Abstract] [Full Text] [Related]

  • 6. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
    Rao GG, Rogers P, Drake RD, Nguyen P, Coleman RL.
    Gynecol Oncol; 2005 Jan 01; 96(1):168-72. PubMed ID: 15589596
    [Abstract] [Full Text] [Related]

  • 7. Final analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer.
    Greven K, Winter K, Underhill K, Fontenesci J, Cooper J, Burke T.
    Gynecol Oncol; 2006 Oct 01; 103(1):155-9. PubMed ID: 16545437
    [Abstract] [Full Text] [Related]

  • 8. Phase I trial of the treatment of high-risk endometrial cancer with concurrent weekly paclitaxel and cisplatin and whole abdominal radiation therapy: a Gynecologic Oncology Group study.
    McMeekin DS, Walker JL, Hartenbach EM, Bookman MA, Koh WJ, Gynecologic Oncology Group.
    Gynecol Oncol; 2009 Jan 01; 112(1):134-41. PubMed ID: 18962846
    [Abstract] [Full Text] [Related]

  • 9. Feasibility study of concurrent weekly cisplatin and whole abdominopelvic irradiation followed by doxorubicin/cisplatin chemotherapy for advanced stage endometrial carcinoma: a Gynecologic Oncology Group trial.
    Soper JT, Reisinger SA, Ashbury R, Jones E, Clarke-Pearson DL.
    Gynecol Oncol; 2004 Oct 01; 95(1):95-100. PubMed ID: 15385116
    [Abstract] [Full Text] [Related]

  • 10. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M, Study Group for Therapies of Rectal Malignancies (STORM).
    Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1129-39. PubMed ID: 16414206
    [Abstract] [Full Text] [Related]

  • 11. Pathologic stage I-II endometrial carcinoma in the elderly: radiotherapy indications and outcome.
    Citron JR, Sutton H, Yamada SD, Mehta N, Mundt AJ.
    Int J Radiat Oncol Biol Phys; 2004 Aug 01; 59(5):1432-8. PubMed ID: 15275729
    [Abstract] [Full Text] [Related]

  • 12. Concurrent cisplatin/radiation followed by adjuvant cisplatin/paclitaxel in treatment of patients with stage IB grade 3, IC and IIA endometrial carcinoma.
    Foad I, Sharawy I, Mostafa E, Margergis M, Hussein T.
    J Egypt Natl Canc Inst; 2007 Jun 01; 19(2):163-9. PubMed ID: 19034346
    [Abstract] [Full Text] [Related]

  • 13. Phase II study of consolidation paclitaxel after concurrent chemoradiation in poor-risk stage III non-small-cell lung cancer: SWOG S9712.
    Davies AM, Chansky K, Lau DH, Leigh BR, Gaspar LE, Weiss GR, Wozniak AJ, Crowley JJ, Gandara DR, SWOG S9712.
    J Clin Oncol; 2006 Nov 20; 24(33):5242-6. PubMed ID: 17114656
    [Abstract] [Full Text] [Related]

  • 14. Prospective evaluation of concurrent paclitaxel and radiation therapy after adjuvant doxorubicin and cyclophosphamide chemotherapy for Stage II or III breast cancer.
    Burstein HJ, Bellon JR, Galper S, Lu HM, Kuter I, Taghian AG, Wong J, Gelman R, Bunnell CA, Parker LM, Garber JE, Winer EP, Harris JR, Powell SN.
    Int J Radiat Oncol Biol Phys; 2006 Feb 01; 64(2):496-504. PubMed ID: 16243442
    [Abstract] [Full Text] [Related]

  • 15. A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.
    Secord AA, Havrilesky LJ, O'Malley DM, Bae-Jump V, Fleming ND, Broadwater G, Cohn DE, Gehrig PA.
    Gynecol Oncol; 2009 Sep 01; 114(3):442-7. PubMed ID: 19560193
    [Abstract] [Full Text] [Related]

  • 16. Adjuvant carboplatin and paclitaxel chemotherapy interposed with involved field radiation for advanced endometrial cancer.
    Lupe K, D'Souza DP, Kwon JS, Radwan JS, Harle IA, Hammond JA, Carey MS.
    Gynecol Oncol; 2009 Jul 01; 114(1):94-8. PubMed ID: 19406459
    [Abstract] [Full Text] [Related]

  • 17. Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I/II study.
    Chung YL, Jian JJ, Cheng SH, Hsieh CI, Tan TD, Chang HJ, Hung CF, Horng CF, Soong T, Tsou MH.
    Gynecol Oncol; 2005 Apr 01; 97(1):126-35. PubMed ID: 15790448
    [Abstract] [Full Text] [Related]

  • 18. Whole-abdominal radiation in endometrial carcinoma: an analysis of toxicity, patterns of recurrence, and survival.
    Small W, Mahadevan A, Roland P, Vallow L, Zusag T, Fishman D, Massad S, Rademaker A, Kalapurakal JA, Chang S, Lurain J.
    Cancer J; 2000 Apr 01; 6(6):394-400. PubMed ID: 11131490
    [Abstract] [Full Text] [Related]

  • 19. Radiation injury to intestine following hysterectomy and adjuvant radiotherapy for cervical cancer.
    Chen SW, Liang JA, Yang SN, Hung YC, Yeh LS, Shiau AC, Lin FJ.
    Gynecol Oncol; 2004 Oct 01; 95(1):208-14. PubMed ID: 15385134
    [Abstract] [Full Text] [Related]

  • 20. Surgically staged high-risk endometrial cancer: randomized study of adjuvant radiotherapy alone vs. sequential chemo-radiotherapy.
    Kuoppala T, Mäenpää J, Tomas E, Puistola U, Salmi T, Grenman S, Lehtovirta P, Fors M, Luukkaala T, Sipilä P.
    Gynecol Oncol; 2008 Aug 01; 110(2):190-5. PubMed ID: 18534669
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.